CIK 0001393434 · Large accelerated filer
OCULAR THERAPEUTIX, INC
Sign in to watch- Ticker
- OCUL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 781-357-4000
- Business address
- 14 CROSBY DRIVE, 3RD FLOOR, BEDFORD, MA, 01730
- Former names
- I-THERAPEUTIX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $799,174
- in 9 filings, $788K under 10b5-1 plans
Net −$799,174. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-10-02 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −9,990 | $7.05 | $70K | 254,388 |
| 2026-08-24 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −3,035 | $10.77 | $33K | 264,378 |
| 2026-05-26 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −2,967 | $8.20 | $24K | 266,141 |
| 2026-02-23 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −2,810 | $8.28 | $23K | 269,108 |
| 2026-01-02 | Kaiser Peter Chief Development Officer | Grant or award | +79,112 | 271,918 | ||
| 2026-01-02 | Kaiser Peter Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +240,932 | 240,932 | ||
| 2025-11-24 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −3,007 | $12.02 | $36K | 191,433 |
| 2025-10-02 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −9,653 | $11.03 | $106K | 194,440 |
| 2025-08-25 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −3,011 | $12.04 | $36K | 204,093 |
| 2025-05-23 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −2,974 | $7.17 | $21K | 207,104 |
| 2025-02-24 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −3,009 | $6.87 | $21K | 210,078 |
| 2024-11-25 | Kaiser Peter Chief Development Officer | Sale 10b5-1 | −2,897 | $9.01 | $26K | 213,087 |
| 2024-10-02 | Kaiser Peter Chief Development Officer | Grant or award | +100,000 | 215,984 | ||
| 2024-10-02 | Kaiser Peter Chief Development Officer | Grant or award · Stock Option (Right to Buy) | +200,000 | 200,000 |
Page 1 of 1 · 14 trades